HuMax-CD20: Start Phase I/II

GEN will begin a dose-escalating, placebo-controlled, international Phase I/II trial

Read the full 109 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE